跳至主要内容
临床试验/NCT00333853
NCT00333853已完成不适用

Self-Monitoring of Blood Glucose Study#1: The Ability of People With Diabetes to Use OneTouch(R) Ultrasmart(tm) to Improve Glycemic Control Through Behavioral and Therapeutic Changes

LifeScan14 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2003年8月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
LifeScan
入组人数
250
试验地点
14
主要终点
Hemoglobin A1c (HbA1c)

研究概览

简要总结

Insulin therapy requires monitoring and frequent review of glucose levels to optimize dosing. Effective presentation and data analysis are essential. We examined HbA1c changes using the OneTouch(R) UltraSmart(R) System (Test Group), an integrated glucose meter and electronic logbook, compared to established meters with paper logbooks (Control Group).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Male or female subjects with type 1 or type 2 insulin-treated diabetes mellitus with a baseline HbA1c greater than or equal to 8.0%.
  • The lower age limit for pediatric subjects was at the discretion of the pediatric investigators and their Institutional Review Board (IRBs).
  • The upper age limit for pediatric subjects was 20 years (i.e., not having reached their 21st birthday on date of enrollment).
  • Subjects must have monitored blood glucose at least 2 times per day. - Subject's current blood glucose meter has download capability, however, the subject did not routinely use this capability on his/her own.

排除标准

  • 未提供

结局指标

主要结局

Hemoglobin A1c (HbA1c)

次要结局

  • Measured hypoglycemia

研究者

发起方
LifeScan
申办方类型
Industry

研究点 (14)

Loading locations...

相似试验

Self-Monitoring of Blood Glucose Study#1: The... | 临床试验